Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|7|563-574

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.7, 2015-01, pp. : 563-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cinacalcet: pharmacological and clinical aspects

By Messa Piergiorgio   Alfieri Carlo   Brezzi Brigida  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 12, 2008-12 ,pp. : 1551-1560

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 1017-1025

Bentham Science Publishers

Access to resources Recommend Favorite

Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism

By Franceschini Nora   Joy Melanie S   Kshirsagar Abhijit  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1413-1421

Informa Healthcare

Access to resources Recommend Favorite

Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-10 ,pp. : 350-370

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Importance of Calcium-Sensing Receptor Gene Polymorphism Arg990Gly in the Age of Calcimimetic Therapy

By  

Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-06 ,pp. : 153-156

Bentham Science Publishers

Access to resources Recommend Favorite